Incontinence News and Research

Latest Incontinence News and Research

First Edition: October 7, 2011

In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.

7 Oct 2011

Hospitalization for an acute event can lead to long-term institutionalization

Confirming many elderly patients' worst fears, a national study has shown that being hospitalized for an acute event, such as a stroke or hip fracture, can lead to long-term institutionalization in a nursing home. Equally alarming, researchers found that direct discharge to a skilled nursing facility -- a common practice designed to reduce hospital stays -- put patients at "extremely high risk" of needing long-term nursing home care.

4 Oct 2011

CCS Medical moves corporate headquarters to Farmers Branch, Texas

CCS Medical today announced the relocation of their corporate headquarters from Clearwater, Florida to Farmers Branch, Texas in the Dallas-Fort Worth Metroplex. CCS Medical has more than 1,500 employees in seven offices across the nation, and is a market leader in distributing home healthcare products and services to patients with chronic conditions in the United States.

1 Oct 2011

Low-tech, inexpensive interventions for bedsores could benefit long-term care residents

Researchers at the University of Toronto have found that low-tech, inexpensive interventions for bedsores could improve health for long-term care residents and reduce health-care costs for the facilities that house them.

29 Sep 2011

Highly prevalent urinary and bladder symptoms will increase further

Nearly half of all adults over 20 will experience at least one lower urinary tract symptom by 2018 - an estimated 2.3 billion people and a worldwide increase of 18% in just one decade - according to research in the October issue of the urology journal BJUI.

28 Sep 2011

Impotence after prostate cancer treatment

According to researchers patients undergoing treatment for prostate cancer could be at a risk of impotence. According to the new study, published in the Journal of the American Medical Association there may be a formula to help gauge those risks for three common types of treatment, including surgery and radiation.

21 Sep 2011

DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products

DryDiapersPlus is excited to announce that they have joined with Unique Wellness and BIOTX Ltd to provide world-class incontinence products for their customers.

16 Sep 2011

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Boston Scientific Corporation today issued the following statement from John Pedersen, Senior Vice President and President of the Company's Urology and Women's Health Division, following the conclusion of a two-day meeting of the U.S. Food and Drug Administration (FDA) Obstetrics & Gynecology Devices Advisory Committee.

12 Sep 2011

Scientists discover 29 new genetic variants linked with MS

Multiple sclerosis is primarily an immunological disease. Scientists at Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine (MDC) have in succeeded, in collaboration with 23 research teams from 15 different countries, in discovering a total of 29 new genetic variants that are involved in the genesis of multiple sclerosis (MS), an inflammatory disease of the nervous system.

7 Sep 2011

Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells

Cryo-Save, Europe's leading family stem cell bank launches its unique Cryo-Lip service in the U.S. offering people the possibility to store their stem cells from fat tissue for future use.

31 Aug 2011

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Astellas Pharma Inc. today announced the submission of a New Drug Application and Market Authorisation Application for mirabegron to the U.S. Food and Drug Administration and the European Medicines Agency.

29 Aug 2011

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.

25 Aug 2011

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.

25 Aug 2011

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

25 Aug 2011

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.

17 Aug 2011

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.

12 Aug 2011

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Researchers have built the first functional anal sphincters in the laboratory, suggesting a potential future treatment for both fecal and urinary incontinence. Made from muscle and nerve cells, the sphincters developed a blood supply and maintained function when implanted in mice.

10 Aug 2011

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Nearly half of men undergoing surgery for prostate cancer expect better recovery from the side effects of the surgery than they actually attain one year after the operation, a University of Michigan Comprehensive Cancer Center study finds.

10 Aug 2011

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan is pleased to announce that BOTOX has received a positive opinion from the Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO) resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis.

8 Aug 2011

A guide to safe and informed recovery after prostate cancer

Prostate cancer is the number two killer of American men, second only to lung cancer. It is a disease that affects more than 2 million American men, and in 2010 there were over 218,000 new diagnoses.

2 Aug 2011

Incontinence News and Research

Latest Incontinence News and Research

First Edition: October 7, 2011

Hospitalization for an acute event can lead to long-term institutionalization

CCS Medical moves corporate headquarters to Farmers Branch, Texas

Low-tech, inexpensive interventions for bedsores could benefit long-term care residents

Highly prevalent urinary and bladder symptoms will increase further

Impotence after prostate cancer treatment

DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Scientists discover 29 new genetic variants linked with MS

Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Allergan receives positive opinion from Irish Medicines Board for BOTOX

A guide to safe and informed recovery after prostate cancer

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Incontinence News and Research

Latest Incontinence News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in